HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2019, 21, N4 (pages: 27 - 34)

Cross-Sectional Study on the Need to Provide Contraceptive Services to Women Attending Opioid-Substitution Therapy

Olioff J., O Shea T., Horan A., Naughton A.M., and O'Brien D.

Summary: Background. Women with opioid use disorders who have unintended pregnancies face unique challenges. A common strategy for preventing unintended pregnancies among these women is to increase their use of long acting reversible contraception (LARC), especially the implant and intrauterine device. This study aimed to assess the pregnancy history, contraceptive use and access to contraceptive services of women attending Cork-Kerry Community Healthcare (CKCH) for opioid replacement therapy. The need for a contraceptive service within the Addiction Services at CKCH was evaluated. Methods. The study utilized a cross-sectional survey administered by healthcare providers to 39 women, ages 18-50, attending CKCH for opioid replacement therapy. Descriptive statistics were performed using IBM SPSS Statistics Data Editor. Results. 79.5% of participants had unintended pregnancies, and 23% had 3 or more unintended pregnancies. Of the participants' children, 35% lived with their mother, 37% lived in care, and 24% lived with another family member. 31% of participants reported never having used LARC. 18% of participants reported never having received information on pregnancy prevention and 21% reported never having received information on STI prevention. 92% of participants reported that they would use a contraceptive service if it were provided within the addiction services at CKCH. Conclusions. This study highlights the need to increase contraceptive services for women attending CKCH for opioid replacement therapy. Addiction services are ideal locations to also access contraceptive services because service-users already attend these clinics frequently for treatment, and thus have continuity of care with healthcare providers.

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page